Aspirin: 120 years of innovation. A report from the 2017 Scientific Conference of the International Aspirin Foundation, 14 September 2017,Charité, Berlin

Bianca Rocca, Jaqui Walker, Pippa Hutchison, Junbo Ge, Dong Zhao, Yongjun Wang, Peter M. Rothwell, J. Michael Gaziano, Andrew Chan, John Burn, John Chia, Ruth Langley, Valerie O'Donnell, Chris Hawkey

Risultato della ricerca: Contributo in rivistaArticolo in rivistapeer review

2 Citazioni (Scopus)

Abstract

Acetylsalicylic acid was first synthesised by Dr FeIix Hoffman on 10th August 1897 and Aspirin was born. It quickly became the best-known pain killer in the world and in the 120 years since this event, aspirin has continued to attract interest, innovation and excitement. Set within the walls of the preserved ruins of Rudolf Virchow's lecture hall at Charité, within Berlin's Museum of Medical History, the International Aspirin Foundation's 28th Scientific Conference served to facilitate international, multi-disease, multidisciplinary discussion about the current understanding of aspirin's mechanisms of action and its utility in modern medicine as well as ideas for future research into its multifaceted applications to enhance global health.
Lingua originaleEnglish
pagine (da-a)813-820
Numero di pagine8
Rivistaecancermedicalscience
Volume12
DOI
Stato di pubblicazionePubblicato - 2018

Keywords

  • Cancer Research
  • Lynch syndrome
  • Oncology
  • aspirin
  • benefit
  • bleeding
  • cardiovascular disease (CVD)
  • colorectal cancer (CRC)
  • individualised choice
  • inflammation
  • personalised medicine
  • precision medicine
  • primary prevention
  • risk
  • secondary prevention
  • stroke
  • tertiary prevention

Fingerprint Entra nei temi di ricerca di 'Aspirin: 120 years of innovation. A report from the 2017 Scientific Conference of the International Aspirin Foundation, 14 September 2017,Charité, Berlin'. Insieme formano una fingerprint unica.

Cita questo